• Policy
• Tecentriq fails urothelial carcinoma trial but beneficial
• by Lee, Hye-Kyung Mar 6, 2023 05:56am

• Company
• ‘No regrets...happy to have served at Daiichi Sankyo Korea'
• by Eo, Yun-Ho Mar 6, 2023 05:56am

• Opinion
• [Reporter's view]Is the Drug Price Reduction Act Good?
• by Kim, Jin-Gu Mar 6, 2023 05:56am

• Policy
• Full-fledged competition in the ultra-large market
• by Lee, Tak-Sun Mar 6, 2023 05:56am

• Company
• JAK inhibitor market jumped 2.4 times in 3 years
• by Kim, Jin-Gu Mar 3, 2023 05:57am

• Company
• Obesity mkt grows larger than ever...Saxenda leads mkt
• by Chon, Seung-Hyun Mar 3, 2023 05:57am

• Company
• Organizations and people change
• by Eo, Yun-Ho Mar 3, 2023 05:57am

• Company
• MFDS approves LG Chem’s P3T for new gout drug
• by Hwang, Jin-joon Mar 3, 2023 05:56am

• Company
• Corona drug competition system is imminent
• by Jung, Sae-Im Mar 3, 2023 05:55am

• Company
• Sky Zoster ranked first in sales of shingles vaccine last yr
• by Kim, Jin-Gu Mar 2, 2023 05:53am